In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Native American Children's Safety 
Act''.

SEC. 2. CHARACTER INVESTIGATIONS.

    Section 408 of the Indian Child Protection and Family Violence 
Prevention Act (25 U.S.C. 3207) is amended by adding at the end the 
following:
    ``(d) By Tribal Social Services Agency for Foster Care Placements 
in Tribal Court Proceedings.--
            ``(1) Definitions.--In this subsection:
                    ``(A) Covered individual.--The term `covered 
                individual' includes--
                            ``(i) any individual 18 years of age or 
                        older; and
                            ``(ii) any individual who an Indian tribe 
                        described in paragraph (2)(A) determines is 
                        subject to a character investigation under that 
                        paragraph.
                    ``(B) Foster care placement.--The term `foster care 
                placement' means any action removing an Indian child 
                from a parent or Indian custodian for temporary 
                placement in a foster home or institution or the home 
                of a guardian or conservator if--
                            ``(i) the parent or Indian custodian cannot 
                        have the child returned on demand; and
                            ``(ii) parental rights have not been 
                        terminated.
                    ``(C) Indian custodian.--The term `Indian 
                custodian' means any Indian--
                            ``(i) who has legal custody of an Indian 
                        child under tribal law or custom or under State 
                        law; or
                            ``(ii) to whom temporary physical care, 
                        custody, and control has been transferred by 
                        the parent of the child.
                    ``(D) Parent.--The term `parent' means--
                            ``(i) any biological parent of an Indian 
                        child; or
                            ``(ii) any Indian who has lawfully adopted 
                        an Indian child, including adoptions under 
                        tribal law or custom.
                    ``(E) Tribal court.--The term `tribal court' means 
                a court--
                            ``(i) with jurisdiction over foster care 
                        placements; and
                            ``(ii) that is--
                                    ``(I) a Court of Indian Offenses;
                                    ``(II) a court established and 
                                operated under the code or custom of an 
                                Indian tribe; or
                                    ``(III) any other administrative 
                                body of a tribe that is vested with 
                                authority over foster care placements.
                    ``(F) Tribal social services agency.--The term 
                `tribal social services agency' means the agency of the 
                Federal Government or of an Indian tribe described in 
                paragraph (2)(A) that has the primary responsibility 
                for carrying out foster care services (as of the date 
                on which the proceeding described in paragraph (2)(A) 
                commences) on the Indian reservation of the Indian 
                tribe.
            ``(2) Character investigations before placement.--
                    ``(A) In general.--Except as provided in paragraph 
                (3), no foster care placement shall be ordered in any 
                proceeding over which an Indian tribe has exclusive 
                jurisdiction until the tribal social services agency--
                            ``(i) completes an investigation of the 
                        character of each covered individual who 
                        resides in the household or is employed at the 
                        institution in which the foster care placement 
                        will be made; and
                            ``(ii) concludes that each covered 
                        individual described in clause (i) meets such 
                        standards of character as the Indian tribe 
                        shall establish in accordance with subparagraph 
                        (B).
                    ``(B) Standards of character.--The standards of 
                character described in subparagraph (A)(ii) shall 
                include--
                            ``(i) requirements that each tribal social 
                        services agency described in subparagraph (A)--
                                    ``(I) perform criminal records 
                                checks, including fingerprint-based 
                                checks of national crime information 
                                databases (as defined in section 
                                534(f)(3) of title 28, United States 
                                Code); and
                                    ``(II) check any child abuse and 
                                neglect registry maintained by the 
                                State in which the covered individual 
                                resides for information on the covered 
                                individual, and request any other State 
                                in which the covered individual resided 
                                in the preceding 5 years, to enable the 
                                tribal social services agency to check 
                                any child abuse and neglect registry 
                                maintained by that State for such 
                                information; and
                            ``(ii) any other additional requirement 
                        that the Indian tribe determines is necessary.
                    ``(C) Results.--Except as provided in paragraph 
                (3), no foster care placement shall be ordered in any 
                proceeding described in subparagraph (A) if an 
                investigation described in clause (i) of that 
                subparagraph reveals that a covered individual 
                described in that clause--
                            ``(i) has been found by a Federal, State, 
                        or tribal court to have committed any crime 
                        listed in clause (i) or (ii) of section 
                        471(a)(20)(A) of the Social Security Act (42 
                        U.S.C. 671(a)(20)(A)); or
                            ``(ii) is listed on a registry described in 
                        subparagraph (B)(i)(II).
                    ``(D) Deadline.--Except as provided in paragraph 
                (3), the tribal social services agency shall satisfy 
                the requirements of clauses (i) and (ii) of 
                subparagraph (A) not later than 14 days after the date 
                on which the proceeding described in subparagraph (A) 
                commences.
            ``(3) Emergency placement.--Paragraph (2) shall not apply 
        to an emergency foster care placement, as determined by an 
        Indian tribe described in paragraph (2)(A).
            ``(4) Recertification of foster homes or institutions.--
                    ``(A) In general.--Not later than 180 days after 
                the date of enactment of this subsection, each Indian 
                tribe shall establish procedures to recertify homes or 
                institutions in which foster care placements are made.
                    ``(B) Contents.--The procedures described in 
                subparagraph (A) shall include, at a minimum, periodic 
                intervals at which the home or institution shall be 
                subject to recertification to ensure--
                            ``(i) the safety of the home or institution 
                        for the Indian child; and
                            ``(ii) that each covered individual who 
                        resides in the home or is employed at the 
                        institution is subject to a character 
                        investigation in accordance with this 
                        subsection, including any covered individual 
                        who--
                                    ``(I) resides in the home or is 
                                employed at the institution on the date 
                                on which the procedures established 
                                under subparagraph (A) commences; and
                                    ``(II) did not reside in the home 
                                or was not employed at the institution 
                                on the date on which the investigation 
                                described in paragraph (2)(A)(i) was 
                                completed.
                    ``(C) Regulations promulgated or guidance issued by 
                the secretary.--The procedures established under 
                subparagraph (A) shall be subject to any regulation 
                promulgated or guidance issued by the Secretary that is 
                in accordance with the purpose of this subsection.
            ``(5) Regulations.--Not later than 180 days after the date 
        of enactment of this subsection and after consultation with 
        Indian tribes, the Secretary shall promulgate a regulation 
        regarding--
                    ``(A) procedures for a character investigation of 
                any covered individual who--
                            ``(i) resides in the home or is employed at 
                        the institution in which the foster care 
                        placement is made after the date on which the 
                        investigation described in paragraph (2)(A)(i) 
                        is completed; and
                            ``(ii) was not the subject of an 
                        investigation described in paragraph (2)(A)(i) 
                        before the foster care placement was made;
                    ``(B) self-reporting requirements for foster care 
                homes or institutions in which any covered individual 
                described in subparagraph (A) resides if the head of 
                the household or the operator of the institution has 
                knowledge that the covered individual--
                            ``(i) has been found by a Federal, State, 
                        or tribal court to have committed any crime 
                        listed in clause (i) or (ii) of section 
                        471(a)(20)(A) of the Social Security Act (42 
                        U.S.C. 671(a)(20)(A)); or
                            ``(ii) is listed on a registry described in 
                        paragraph (2)(B)(i)(II);
                    ``(C) procedures and guidelines for emergency 
                foster care placements under paragraph (3); and
                    ``(D) procedures for certifying compliance with 
                this Act.''.

A: Native American Children's Safety Act - Amends the Indian Child Protection and Family Violence Prevention Act (Act) to prohibit any foster care placement over which an Indian tribe has exclusive jurisdiction from being ordered until the tribal social services agency: (1) completes an investigation of the character of each covered individual who resides in the household or is employed at the institution in which the foster care placement will be made, and (2) concludes that each of those individuals meets the standards of character the tribe is required to establish.  Defines a &quot;covered individual&quot; as an adult and any other individual the tribe determines is subject to such character investigation. Requires the tribal social services agency, as part of those investigations, to: (1) perform criminal records checks, including fingerprint-based checks of national crime information databases; (2) check any child abuse and neglect registry maintained by the state in which the individual resides; and (3) request any other state in which the individual resided during the preceding five years to allow the agency to check its registry. Prohibits a foster care placement from being ordered if the investigation reveals that the covered individual: (1) has been found guilty by a federal, state, or tribal court of a felony involving child abuse or neglect, spousal abuse, a crime against a child, violence, or drugs; or (2) is listed on a child abuse and neglect registry in the state where the individual resides or resided within the preceding five years. Excepts emergency foster care placements from such requirements. Requires each Indian tribe to establish procedures to recertify homes or institutions in which foster care placements are made. Directs the Secretary of the Interior to promulgate a regulation establishing: (1) procedures for investigating the character of any covered individual who resides in the home or is employed at the institution in which the child is placed after the investigations that preceded that placement occurred, (2) self-reporting requirements for foster care homes or institutions that have knowledge that a covered individual residing on their premises would fail the character investigation, (3) procedures and guidelines for emergency foster care placements, and (4) procedures for certifying compliance with the Act.
****
Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Right to Try Act''.

SEC. 2. USE OF UNAPPROVED MEDICAL PRODUCTS BY PATIENTS DIAGNOSED WITH A 
              TERMINAL ILLNESS.

    (a) In General.--Notwithstanding the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 301 et seq.), the Controlled Substances Act (21 
U.S.C. 801 et seq.), and any other provision of Federal law, the 
Federal Government shall not take any action to prohibit or restrict--
            (1) the production, manufacture, distribution, prescribing, 
        or dispensing of an experimental drug, biological product, or 
        device that--
                    (A) is intended to treat a patient who has been 
                diagnosed with a terminal illness; and
                    (B) is authorized by, and in accordance with, State 
                law; and
            (2) the possession or use of an experimental drug, 
        biological product, or device--
                    (A) that is described in subparagraphs (A) and (B) 
                of paragraph (1); and
                    (B) for which the patient has received a 
                certification from the patient's treating physician in 
                accordance with subsection (b).
    (b) Physician Certification.--A certification by the patient's 
treating physician referred to in subsection (a)(2)(B) must include 
each of the following:
            (1) A certification that the physician--
                    (A) is in good standing with the physician's 
                certifying organization or board; and
                    (B) has personally examined the patient.
            (2) A certification that there is no reason to conclude the 
        experimental drug, biological product, or device poses an 
        unreasonable and significant risk of danger to the patient.
            (3) A certification that the patient has been diagnosed 
        with a terminal disease or condition and does not have any 
        treatment options that--
                    (A) are comparable to treatment using the 
                experimental drug, biological product, or device or 
                otherwise satisfactory; and
                    (B) are approved, licensed, or cleared for 
                commercial distribution under section 505, 510(k), or 
                515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262) and are 
                available to diagnose, monitor, or treat the patient's 
                disease or condition.
            (4) A certification that the probable risk to the patient 
        from the experimental drug, biological product, or device is 
        not greater than the probable risk from the patient's disease 
        or condition.
            (5) A certification that the physician has provided the 
        patient with a written statement and oral explanation of the 
        medical treatment to be provided using the experimental drug, 
        biological product, or device.
            (6) An acknowledgement signed by the patient (or the 
        patient's legal representative) that the physician has provided 
        the written statement and oral explanation required by 
        paragraph (5), and has disclosed the following:
                    (A) That the medical treatment using the 
                experimental drug, biological product, or device is 
                experimental or nonconventional.
                    (B) That the experimental drug, biological product, 
                or device has not been approved, licensed, or cleared 
                for commercial distribution under section 505, 510(k), 
                or 515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262) for any 
                indication.
                    (C) The material risks generally recognized by a 
                reasonably prudent physician of the medical treatment's 
                side effects.
                    (D) An explanation of the medical treatment, 
                including the expected frequency and duration of the 
                treatment.
    (c) No Liability or Use of Outcomes.--
            (1) No liability.--Notwithstanding any other provision of 
        law, no liability shall lie against a producer, manufacturer, 
        distributor, prescriber, dispenser, possessor, or user of an 
        experimental drug, biological product, or device for the 
        production, manufacture, distribution, prescribing, dispensing, 
        possession, or use of an experimental drug, biological product, 
        or device that is in compliance, with subsection (a).
            (2) No use of outcomes.--Notwithstanding any other 
        provision of law, the outcome of any production, manufacture, 
        distribution, prescribing, dispensing, possession, or use of an 
        experimental drug, biological product, or device that was done 
        in compliance with subsection (a) shall not be used by a 
        Federal agency reviewing the experimental drug, biological 
        product, or device to delay or otherwise adversely impact 
        review or approval of such experimental drug, biological 
        product, or device.
    (d) Rules of Construction.--Nothing in this Act shall be construed 
to--
            (1) require a manufacturer or other person to make 
        available any experimental drug, biological product, or device; 
        or
            (2) prohibit a manufacturer or other person from receiving 
        compensation or recovering costs for the production, 
        manufacture, distribution, or sale of an experiment drug, 
        biological product, or device.
    (e) Definitions.--In this section:
            (1) Biological product.--The term ``biological product'' 
        has the meaning given to such term in section 351 of the Public 
        Health Service Act (42 U.S.C. 262).
            (2) Device; drug.--The terms ``device'' and ``drug'' have 
        the meanings given to such terms in section 201 of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 321).
            (3) Experimental drug, biological product, or device.--The 
        term ``experimental drug, biological product, or device'' means 
        a drug, biological product, or device that--
                    (A) has successfully completed a phase 1 clinical 
                investigation;
                    (B) remains under investigation in a clinical trial 
                approved by the Food and Drug Administration; and
                    (C) is not approved, licensed, or cleared for 
                commercial distribution under section 505, 510(k), or 
                515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262).
            (4) Phase 1 clinical investigation.--The term ``phase 1 
        clinical investigation'' means a phase 1 clinical 
        investigation, as described in section 312.21 of title 21, Code 
        of Federal Regulations (or any successor regulations).
            (5) Terminal illness.--The term ``terminal illness'' has 
        the meaning given to such term in the State law specified in 
        subsection (a)(1)(B).

A: Right to Try Act This bill requires the federal government to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are authorized by state law and intended to treat terminally ill patients. Patients receiving these treatments must be certified by a physician as having exhausted all other treatment options and as being at greater risk from their medical condition than the treatment. The physician must explain the treatment to the patient, including that the treatment is experimental, and the patient, or the patient's legal representative, must acknowledge the explanation. A manufacturer, distributor, prescriber, dispenser, possessor, or user of such a treatment has no liability regarding the treatment. The outcome of manufacture, distribution, prescribing, dispensing, possession, or use of such a treatment may not be used by a federal agency to adversely impact review or approval of the treatment. The treatment must: (1) have successfully completed a phase 1 (initial, small scale) clinical trial; (2) remain under investigation in a clinical trial approved by the Food and Drug Administration (FDA); and (3) not be approved, licensed, or cleared for sale by the FDA.  
****
Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Lower Delaware Wild and Scenic 
Rivers Act''.

SEC. 2. FINDINGS.

    Congress finds that--
        (1) Public Law 102-460 directed the Secretary of the Interior, 
    in cooperation and consultation with appropriate Federal, State, 
    regional, and local agencies, to conduct a study of the eligibility 
    and suitability of the lower Delaware River for inclusion in the 
    Wild and Scenic Rivers System;
        (2) during the study, the Lower Delaware Wild and Scenic River 
    Study Task Force and the National Park Service prepared a river 
    management plan for the study area entitled ``Lower Delaware River 
    Management Plan'' and dated August 1997, which establishes goals 
    and actions that will ensure long-term protection of the river's 
    outstanding values and compatible management of land and water 
    resources associated with the river; and
        (3) after completion of the study, 24 municipalities along 
    segments of the Delaware River eligible for designation passed 
    resolutions supporting the Lower Delaware River Management Plan, 
    agreeing to take action to implement the goals of the plan, and 
    endorsing designation of the river.

SEC. 3 DESIGNATION.

    Section 3(a) of the Wild and Scenic Rivers Act (16 U.S.C. 1274(a)) 
is amended--
        (1) by designating the first undesignated paragraph following 
    paragraph 156, pertaining to Elkhorn Creek and enacted by Public 
    Law 104-208, as paragraph 157;
        (2) by designating the second undesignated paragraph following 
    paragraph 156, pertaining to the Clarion River, Pennsylvania, and 
    enacted by Public Law 104-314, as paragraph 158;
        (3) by designating the third undesignated paragraph following 
    paragraph 156, pertaining to the Lamprey River, New Hampshire, and 
    enacted by Public Law 104-333, as paragraph 159;
        (4) by striking the fourth undesignated paragraph following 
    paragraph 156, pertaining to Elkhorn Creek and enacted by Public 
    Law 104-333; and
        (5) by adding at the end the following:
        ``(161) Lower delaware river and associated tributaries, new 
    jersey and pennsylvania.--(A) The 65.6 miles of river segments in 
    New Jersey and Pennsylvania, consisting of--
            ``(i) the segment from river mile 193.8 to the northern 
        border of the city of Easton, Pennsylvania (approximately 10.5 
        miles), as a recreational river;
            ``(ii) the segment from a point just south of the Gilbert 
        Generating Station to a point just north of the Point Pleasant 
        Pumping Station (approximately 14.2 miles), as a recreational 
        river;
            ``(iii) the segment from the point just south of the Point 
        Pleasant Pumping Station to a point 1,000 feet north of the 
        Route 202 bridge (approximately 6.3 miles), as a recreational 
        river;
            ``(iv) the segment from a point 1,750 feet south of the 
        Route 202 bridge to the southern border of the town of New 
        Hope, Pennsylvania (approximately 1.9 miles), as a recreational 
        river;
            ``(v) the segment from the southern boundary of the town of 
        New Hope, Pennsylvania, to the town of Washington Crossing, 
        Pennsylvania (approximately 6 miles), as a recreational river;
            ``(vi) Tinicum Creek (approximately 14.7 miles), as a 
        scenic river;
            ``(vii) Tohickon Creek from the Lake Nockamixon Dam to the 
        Delaware River (approximately 10.7 miles), as a scenic river; 
        and
            ``(viii) Paunacussing Creek in Solebury Township 
        (approximately 3 miles), as a recreational river.
        ``(B) Administration.--The river segments referred to in 
    subparagraph (A) shall be administered by the Secretary of the 
    Interior. Notwithstanding section 10(c), the river segments shall 
    not be administered as part of the National Park System.''.

SEC. 4. MANAGEMENT OF RIVER SEGMENTS.

    (a) Management of Segments.--The river segments designated in 
section 3 shall be managed--
        (1) in accordance with the river management plan entitled 
    ``Lower Delaware River Management Plan'' and dated August 1997 
    (referred to as the ``management plan''), prepared by the Lower 
    Delaware Wild and Scenic River Study Task Force and the National 
    Park Service, which establishes goals and actions that will ensure 
    long-term protection of the river's outstanding values and 
    compatible management of land and water resources associated with 
    the river; and
        (2) in cooperation with appropriate Federal, State, regional, 
    and local agencies, including--
            (A) the New Jersey Department of Environmental Protection;
            (B) the Pennsylvania Department of Conservation and Natural 
        Resources;
            (C) the Delaware and Lehigh Navigation Canal Heritage 
        Corridor Commission;
            (D) the Delaware and Raritan Canal Commission; and
            (E) the Delaware River Greenway Partnership.
    (b) Satisfaction of Requirements for Plan.--The management plan 
shall be considered to satisfy the requirements for a comprehensive 
management plan under subsection 3(d) of the Wild and Scenic Rivers Act 
(16 U.S.C. 1274(d)).
    (c) Federal Role.--
        (1) Restrictions on water resource projects.--In determining 
    under section 7(a) of the Wild and Scenic Rivers Act (16 U.S.C. 
    1278(a)) whether a proposed water resources project would have a 
    direct and adverse effect on the value for which a segment is 
    designated as part of the Wild and Scenic Rivers System, the 
    Secretary of the Interior (hereinafter referred to as the 
    ``Secretary'') shall consider the extent to which the project is 
    consistent with the management plan.
        (2) Cooperative agreements.--Any cooperative agreements entered 
    into under section 10(e) of the Wild and Scenic Rivers Act (16 
    U.S.C. 1281(e)) relating to any of the segments designated by this 
    Act shall--
            (A) be consistent with the management plan; and
            (B) may include provisions for financial or other 
        assistance from the United States to facilitate the long-term 
        protection, conservation, and enhancement of the segments.
        (3) Support for implementation.--The Secretary may provide 
    technical assistance, staff support, and funding to assist in the 
    implementation of the management plan.
    (d) Land Management.--
        (1) In general.--The Secretary may provide planning, financial, 
    and technical assistance to local municipalities to assist in the 
    implementation of actions to protect the natural, economic, and 
    historic resources of the river segments designated by this Act.
        (2) Plan requirements.--After adoption of recommendations made 
    in section III of the management plan, the zoning ordinances of the 
    municipalities bordering the segments shall be considered to 
    satisfy the standards and requirements under section 6(c) of the 
    Wild and Scenic Rivers Act (16 U.S.C. 1277(c)).
    (e) Additional Segments.--
        (1) In general.--In this paragraph, the term ``additional 
    segment'' means--
            (A) the segment from the Delaware Water Gap to the Toll 
        Bridge connecting Columbia, New Jersey, and Portland, 
        Pennsylvania (approximately 9.2 miles), which, if made part of 
        the Wild and Scenic Rivers System in accordance with this 
        paragraph, shall be administered by the Secretary as a 
        recreational river;
            (B) the segment from the Erie Lackawanna railroad bridge to 
        the southern tip of Dildine Island (approximately 3.6 miles), 
        which, if made part of the Wild and Scenic Rivers System in 
        accordance with this paragraph, shall be administered by the 
        Secretary as a recreational river;
            (C) the segment from the southern tip of Mack Island to the 
        northern border of the town of Belvidere, New Jersey 
        (approximately 2 miles), which, if made part of the Wild and 
        Scenic Rivers System in accordance with this paragraph, shall 
        be administered by the Secretary as a recreational river;
            (D) the segment from the southern border of the town of 
        Phillipsburg, New Jersey, to a point just north of Gilbert 
        Generating Station (approximately 9.5 miles), which, if made 
        part of the Wild and Scenic Rivers System in accordance with 
        this paragraph, shall be administered by the Secretary as a 
        recreational river;
            (E) Paulinskill River in Knowlton Township (approximately 
        2.4 miles), which, if made part of the Wild and Scenic Rivers 
        System in accordance with this paragraph, shall be administered 
        by the Secretary as a recreational river; and
            (F) Cook's Creek (approximately 3.5 miles), which, if made 
        part of the Wild and Scenic Rivers System in accordance with 
        this paragraph, shall be administered by the Secretary as a 
        scenic river.
        (2) Finding.--Congress finds that each of the additional 
    segments is suitable for designation as a recreational river or 
    scenic river under this paragraph, if there is adequate local 
    support for the designation.
        (3) Designation.--If the Secretary finds that there is adequate 
    local support for designating any of the additional segments as a 
    recreational river or scenic river--
            (A) the Secretary shall publish in the Federal Register a 
        notice of the designation of the segment; and
            (B) the segment shall thereby be designated as a 
        recreational river or scenic river, as the case may be, in 
        accordance with the Wild and Scenic Rivers Act (16 U.S.C. 1271 
        et seq.).
        (4) Criteria for local support.--In determining whether there 
    is adequate local support for the designation of an additional 
    segment, the Secretary shall consider, among other things, the 
    preferences of local governments expressed in resolutions 
    concerning designation of the segment.

SEC. 5. AUTHORIZATION OF APPROPRIATIONS.

    There is authorized to be appropriated such sums as are necessary 
to carry out this Act.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.

A:
Requires such segments to be managed: (1) in accordance with the Lower Delaware River management plan which ensures the long-term protection of the River's values and the compatible management of land and water resources associated with the River; and (2) in cooperation with appropriate Federal, State, regional, and local agencies.
Authorizes the Secretary: (1) to provide planning, financial, and technical assistance to affected local municipalities to protect the natural, economic, and historic resources of the segments; and (2) if adequate local support to add certain additional segments to the System is found, to publish a notice of such designation, after which such segments shall be so included.
Authorizes appropriations.
****